|
ARID2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.908600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.918400E-01 |
| Normal-vs-Stage2 |
4.935400E-01 |
| Normal-vs-Stage3 |
1.969410E-01 |
| Normal-vs-Stage4 |
2.893500E-02 |
| Stage1-vs-Stage2 |
6.568400E-01 |
| Stage1-vs-Stage3 |
2.423400E-01 |
| Stage1-vs-Stage4 |
2.494000E-02 |
| Stage2-vs-Stage3 |
7.076000E-01 |
| Stage2-vs-Stage4 |
2.937400E-01 |
| Stage3-vs-Stage4 |
3.561600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.412400E-01 |
| Normal-vs-AfricanAmerican |
1.776380E-02 |
| Normal-vs-Asian |
1.926180E-01 |
| Caucasian-vs-AfricanAmerican |
4.274000E-02 |
| Caucasian-vs-Asian |
1.381390E-01 |
| AfricanAmerican-vs-Asian |
8.999900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.567950E-01 |
| Normal-vs-Female |
7.738000E-01 |
| Male-vs-Female |
1.105830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.480500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.408800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.734200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.469600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.768200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.654010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.640800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.711200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.442220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.702800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.110200E-01 |
| Normal-vs-Grade 2 |
9.168600E-01 |
| Normal-vs-Grade 3 |
1.201770E-01 |
| Normal-vs-Grade 4 |
1.315640E-03 |
| Grade 1-vs-Grade 2 |
4.191800E-01 |
| Grade 1-vs-Grade 3 |
6.926300E-02 |
| Grade 1-vs-Grade 4 |
3.158500E-03 |
| Grade 2-vs-Grade 3 |
3.485900E-02 |
| Grade 2-vs-Grade 4 |
1.044980E-04 |
| Grade 3-vs-Grade 4 |
2.558300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.039400E-01 |
| Normal-vs-ccB subtype |
7.504100E-02 |
| ccA subtype-vs-ccB subtype |
3.560900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.394000E-01 |
| Normal-vs-N1 |
5.170000E-01 |
| N0-vs-N1 |
7.764800E-01 |
|
|
